Table 2 Kaplan-Meier survival analysis for STX4 in pan-cancer (33 types of cancer from TCGA)
Abbreviation | Detail | Log-rank test p value |
|---|---|---|
ACC | Adrenocortical carcinoma | 0.277 |
BLCA | Bladder Urothelial Carcinoma | 0.702 |
BRCA | Breast invasive carcinoma | 0.954 |
CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | 0.009 |
CHOL | Cholangio carcinoma | 0.675 |
COAD | Colon adenocarcinoma | 0.618 |
DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | 0.629 |
ESCA | Esophageal carcinoma | 0.309 |
GBM | Glioblastoma multiforme | 0.098 |
HNSC | Head and Neck squamous cell carcinoma | 0.438 |
KICH | Kidney Chromophobe | 0.133 |
KIRC | Kidney renal clear cell carcinoma | 0.000 |
KIRP | Kidney renal papillary cell carcinoma | 0.573 |
LAML | Acute Myeloid Leukemia | 0.185 |
LGG | Brain Lower Grade Glioma | 0.888 |
LIHC | Liver hepatocellular carcinoma | 0.102 |
LUAD | Lung adenocarcinoma | 0.801 |
LUSC | Lung squamous cell carcinoma | 0.936 |
MESO | Mesothelioma | 0.319 |
OV | Ovarian serous cystadenocarcinoma | 0.943 |
PAAD | Pancreatic adenocarcinoma | 0.733 |
PCPG | Pheochromocytoma and Paraganglioma | 0.453 |
PRAD | Prostate adenocarcinoma | 0.161 |
READ | Rectum adenocarcinoma | 0.766 |
SARC | Sarcoma | 0.442 |
SKCM | Skin Cutaneous Melanoma | 0.026 |
STAD | Stomach adenocarcinoma | 0.155 |
TGCT | Testicular Germ Cell Tumors | 0.315 |
THCA | Thyroid carcinoma | 0.445 |
THYM | Thymoma | 0.656 |
UCEC | Uterine Corpus Endometrial Carcinoma | 0.832 |
UCS | Uterine Carcinosarcoma | 0.248 |
UVM | Uveal Melanoma | 0.003 |